IRIS
BRUNO, RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.856
AS - Asia 8.635
EU - Europa 6.717
SA - Sud America 1.464
AF - Africa 322
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 16
AN - Antartide 1
Totale 28.033
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.570
CN - Cina 3.521
SG - Singapore 2.111
IE - Irlanda 1.305
BR - Brasile 1.121
HK - Hong Kong 1.013
VN - Vietnam 1.002
RU - Federazione Russa 916
IT - Italia 910
DE - Germania 789
FI - Finlandia 612
UA - Ucraina 594
FR - Francia 485
GB - Regno Unito 341
SE - Svezia 292
IN - India 228
ZA - Sudafrica 167
CA - Canada 146
BD - Bangladesh 123
AR - Argentina 120
MX - Messico 90
NL - Olanda 87
IQ - Iraq 83
TR - Turchia 78
JP - Giappone 75
ES - Italia 66
PL - Polonia 66
ID - Indonesia 57
PK - Pakistan 53
EC - Ecuador 52
BE - Belgio 48
VE - Venezuela 43
CO - Colombia 39
SA - Arabia Saudita 35
CZ - Repubblica Ceca 34
UZ - Uzbekistan 33
MA - Marocco 31
TN - Tunisia 29
AT - Austria 28
PH - Filippine 27
CL - Cile 23
LT - Lituania 22
IL - Israele 19
PY - Paraguay 19
MY - Malesia 18
AU - Australia 17
CH - Svizzera 17
AZ - Azerbaigian 16
EG - Egitto 16
JO - Giordania 16
KZ - Kazakistan 15
PE - Perù 15
JM - Giamaica 14
RO - Romania 14
IR - Iran 13
UY - Uruguay 13
AE - Emirati Arabi Uniti 12
KE - Kenya 12
ET - Etiopia 11
NP - Nepal 11
AL - Albania 10
BO - Bolivia 10
DZ - Algeria 10
EU - Europa 10
PT - Portogallo 10
BY - Bielorussia 9
KG - Kirghizistan 9
LB - Libano 9
SN - Senegal 9
MU - Mauritius 8
OM - Oman 8
PA - Panama 8
TH - Thailandia 8
CR - Costa Rica 7
GE - Georgia 7
HU - Ungheria 7
HR - Croazia 6
LV - Lettonia 6
SK - Slovacchia (Repubblica Slovacca) 6
BG - Bulgaria 5
MD - Moldavia 5
RS - Serbia 5
AM - Armenia 4
DO - Repubblica Dominicana 4
GY - Guiana 4
KR - Corea 4
LK - Sri Lanka 4
LY - Libia 4
NI - Nicaragua 4
NO - Norvegia 4
SR - Suriname 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
BH - Bahrain 3
CG - Congo 3
CM - Camerun 3
DK - Danimarca 3
GR - Grecia 3
KW - Kuwait 3
NG - Nigeria 3
Totale 27.968
Salva come PNG Salva come JPEG
Città #
Dublin 1.301
Chandler 1.254
San Jose 1.094
Singapore 1.090
Ashburn 992
Hong Kong 982
Dallas 898
Jacksonville 725
Beijing 651
Nanjing 604
Boardman 442
Ho Chi Minh City 340
Los Angeles 321
Lauterbourg 313
Princeton 268
New York 248
Hanoi 240
Lawrence 235
Nanchang 235
Munich 230
Milan 224
Wilmington 219
Helsinki 216
Shenyang 193
Moscow 183
Hebei 177
Changsha 172
Medford 166
Redondo Beach 144
Johannesburg 139
Ann Arbor 137
Jiaxing 130
Shanghai 128
São Paulo 126
Buffalo 120
Turku 120
Pavia 112
Tianjin 97
Hangzhou 90
Seattle 79
Council Bluffs 74
Orem 74
Tokyo 71
Frankfurt am Main 70
Da Nang 62
Santa Clara 59
Chennai 57
Falkenstein 56
San Francisco 55
Warsaw 55
Woodbridge 55
Montreal 53
Denver 52
Brooklyn 50
Nuremberg 50
Houston 49
Norwalk 46
The Dalles 46
Brussels 45
Toronto 45
Chicago 42
Verona 42
Haiphong 41
London 38
Rio de Janeiro 37
Stockholm 36
Mexico City 35
Poplar 35
Pune 34
Guangzhou 33
Atlanta 32
Rome 32
Washington 32
Amsterdam 31
Fairfield 31
Baghdad 30
Biên Hòa 28
Tashkent 28
Columbus 26
Ankara 25
Manchester 25
Belo Horizonte 24
Zhengzhou 24
Boston 22
Phoenix 22
Curitiba 21
Düsseldorf 21
Brasília 20
Hải Dương 20
Mumbai 20
Quito 20
Dhaka 19
Ningbo 19
Paris 19
Jinan 18
Secaucus 18
Brno 17
Des Moines 17
Kunming 17
New Delhi 17
Totale 17.627
Salva come PNG Salva come JPEG
Nome #
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 321
Hepatitis B virus genotype distribution in HIV-1 coinfected patients 251
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 172
AGGRESSIVE INTERFERON THERAPY IN HIV-HCV COINFECTED PATIENTS 167
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 158
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. 155
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 152
Aggressive daily interferon therapy in HIV-HCV coinfected patients 150
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 149
A mid-term follow-up with a lung ultrasonographic score correlates with the severity of COVID-19 acute phase 146
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 146
Distinct mutational drug resistance profiles of HIV-1 RNA in plasma in culture isolates of patients receiving antiretroviral theraphy 145
Nutritional parameters associated with prognosis in non-critically ill hospitalized COVID-19 patients: The NUTRI-COVID19 study 137
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 136
The Pavia consensus statement 131
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 131
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 131
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 130
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 125
Emergency Department and Out-of-Hospital Emergency System (112—AREU 118) integrated response to Coronavirus Disease 2019 in a Northern Italy centre 124
Mice and rabbits: Animal models for HIV-1 infection 121
Consensus conference on TIPS management: Techniques, indications, contraindications 121
Acute liver failure during lamivudine tratment in a hepatitis B cirrhotic patient 120
Economic evaluation of HIV treatments: The I.CO.N.A. cohort study 119
Host factors affecting the outcome of treatment of hepatitis C 118
Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection. 117
COVID vaccination and asthma exacerbation: might there be a link? 117
Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper 116
[New trends in the therapy of cryptococcosis in AIDS patients] 116
Forecast model for the evaluation of economic resources employed in the health care of patients with HIV infection. 115
Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infection 115
Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital 115
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 114
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 114
Mid-term follow-up chest CT findings in recovered COVID-19 patients with residual symptoms 112
Daptomycin Pharmacokinetics and Pharmacodynamics in Patients on Methadone Substitution Therapy 112
Emerging biological agents for hepatitis C 112
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 112
Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020 112
AISF position paper on liver disease and pregnancy 111
Lopinavir/ritonavir and darunavir/cobicistat in hospitalized covid-19 patients: Findings from the multicenter italian corist study 111
Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop 109
Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis. 109
A case of leprosy in a nonendemic country 109
Challenges for hepatitis C patients coinfected with HIV. 108
Hospitalizations Associated With Mental Health Conditions Among Adolescents in the US and France During the COVID-19 Pandemic 106
Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C. 106
Understanding the Mechanisms of Fibrogenesis in HIV/HCV-Coinfected Patients: Implications for Clinical Practice 106
Epidemiological characteristics of bloodstream infections in patients with different degrees of liver disease 106
Direct-acting Antivirals during or after Immuno-chemotherapy in Hepatitis C Virus-positive Diffuse Large B-cell Lymphomas 106
Daily Interferon therapy in HIV-HCV coinfected patients: Preliminary Report 106
Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol 106
A clinical case of sepsis due to staphylococcus pettenkoferi 105
High Frequencies of Functional Virus-Specific CD4+ T Cells in SARS-CoV-2 Subjects With Olfactory and Taste Disorders 105
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 104
Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts. 104
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 104
Patients with chronic hepatitis C receiving treatment with direct acting antivirals: How is this population changing? 104
Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium 103
Rapid response to COVID-19 outbreak in Northern Italy: how to convert a classic infectious disease ward into a COVID-19 response centre 102
Dissociation between serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus 101
Cutaneous septic emboli from Candida glabrata in a haematological patient 101
Tocilizumab for treatment of severe covid-19 patients: Preliminary results from smatteo covid19 registry (smacore) 101
Fungal Osteomyelitis: A Systematic Review of Reported Cases 100
Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort Study 100
Management of hepatitis C in human immunodeficiency virus-infected patients 100
Transfusion-transmitted virus infection in HIV-1-seropositive patients 100
General issues on microbial translocation in HIV-infected patients 100
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project 99
HCV-VIRAL KINETICS IN DIFFERENT CATEGORIES OF PATIENTS: DAILY VERSUS BID INDUCTION INTERFERON THERAPY 98
Ultrasound in the diagnosis of gallbladder ascariasis 98
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study 97
Area-under-the-curve for peginterferon alpha-2a and peginterferon alpha-2b is not related to body weight in treatment-naive patients with chronic hepatitis C 96
Expression of biomarkers of interferon type I in patients suffering from chronic diseases 95
Comments on the review 'Care of patients with hepatitis C and HIV co-infection' by Soriano et al. 95
Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects 95
Rapid hepatitis B virus-DNA decay in co-infected HIV-hepatitis B virus 'eminus' patients with YMDD mutations after 4 weeks of tenofovir therapy 95
Regression of indolent B-cell lymphoma after Lamivudine prophylaxis of hepatitis B virus infection. 95
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection 95
Management of hepatitis C positive patients undergoing active treatment for malignancies: a position paper from the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Malattie Infettive e Tropicali (SIMIT) 95
Management of infections pre- and post-liver transplantation: report of an AISF consensus conference. 94
The role of the rs12979860 polymorphism of the interleukin-28b as a predictor of sustained virological response after antiviral therapy in patients with hemophilia and chronic hepatitis C 94
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 94
Modelling liver fibrosis progression in chronic hepatitis C: a study of 563 patients with sequential liver biopsies 93
Spatial and temporal dynamics of hepatitis B virus d genotype in europe and the mediterranean basin. 93
Effect of the IL-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in HIV co-infected patients 93
Treatment of echinococcal abdominal cysts 93
Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy 93
Acute Thrombosis of Lower Limbs Arteries in The Acute Phase and after Recovery from COVID19 93
Detection of the SARS-CoV-2 in different biologic specimens from positive patients with COVID-19, in Northern Italy 92
Occult hepatitis B in patients with cancer during immunotherapy with or without chemotherapy: A real-life retrospective single-center cohort study 92
Hepatotoxicity and nelfinavir: a meta-analysis 92
Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT 92
Specificity and sensitivity of 3rd generation EIA for detection of HCV antibodies among intravenous drug-users 92
Characterization of long COVID temporal sub-phenotypes by distributed representation learning from electronic health record data: a cohort study 91
The Bio-Diversity and the Role of Gut Microbiota in Postmenopausal Women with Luminal Breast Cancer Treated with Aromatase Inhibitors: An Observational Cohort Study 91
Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas. 91
High prevalence of metabolic syndrome among HIV-infected patients: link with the cardiovascular risk 91
Myocarditis in a 16-year-old boy positive for SARS-CoV-2 91
Acute arterial and deep venous thromboembolism in COVID-19 patients: Risk factors and personalized therapy 91
Totale 11.387
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.906
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.906
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021361 0 0 0 0 0 0 0 0 0 161 151 49
2021/20221.112 34 14 22 11 28 30 23 73 76 18 151 632
2022/20233.645 386 248 40 286 323 368 7 192 1.541 49 145 60
2023/20241.725 173 271 73 88 222 378 91 130 13 64 74 148
2024/20255.349 111 349 103 179 82 238 472 362 1.279 279 599 1.296
2025/202611.509 934 953 1.343 1.468 1.479 548 2.368 557 1.088 771 0 0
Totale 28.510